Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review

  • ID: 4391477
  • SWOT Analysis
  • 40 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Ambry Genetics Corp
  • Counsyl Inc
  • Foundation Medicine Inc
  • GeneDX Inc
  • InVitae Corp
  • Myriad Genetics Inc
  • MORE
Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the Author to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Fulgent Genetics Inc (Fulgent) is a provider of clinically diagnostic genetic testing and genetic information to physicians for improving the quality of patient care. The company offers a wide range of testing options through its proprietary technology platform that integrates genetic diagnostics tools with adaptive learning software, data comparison and suppression algorithms, and laboratory processes. It combines next generation sequencing with its technology platform to offer full-gene sequencing with deletion or duplication analysis in single-gene tests, pre-established, multi-gene, disease-specific panels and customized panels for specific customer needs. The company offers commercial genetic tests for rare paediatric diseases, paediatric tests single-gene tests, and genetic tests for various cardiovascular diseases, neurological disorders, and cancers. Fulgent is headquartered in Temple City, California, the US.

Fulgent Genetics Inc Key Recent Developments

Aug 06,2018: Fulgent Genetics reports second quarter 2018 financial results
May 07,2018: Fulgent Genetics Reports First Quarter 2018 Financial Results
Feb 28,2018: Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 06,2017: Fulgent Genetics Reports Third Quarter 2017 Financial Results
Sep 14,2017: FDNA Teams with World’s Top Genetic Labs to Advance Genetic Testing for Rare Diseases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ambry Genetics Corp
  • Counsyl Inc
  • Foundation Medicine Inc
  • GeneDX Inc
  • InVitae Corp
  • Myriad Genetics Inc
  • MORE
Section 1 - About the Company
Fulgent Genetics Inc - Key Facts
Fulgent Genetics Inc - Key Employees
Fulgent Genetics Inc - Key Employee Biographies
Fulgent Genetics Inc - Major Products and Services
Fulgent Genetics Inc - History
Fulgent Genetics Inc - Company Statement
Fulgent Genetics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
Fulgent Genetics Inc - Business Description
R&D Overview
Fulgent Genetics Inc - SWOT Analysis
SWOT Analysis - Overview
Fulgent Genetics Inc - Strengths
Fulgent Genetics Inc - Weaknesses
Fulgent Genetics Inc - Opportunities
Fulgent Genetics Inc - Threats
Fulgent Genetics Inc - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Fulgent Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Fulgent Genetics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments
Aug 06, 2018: Fulgent Genetics reports second quarter 2018 financial results
May 07, 2018: Fulgent Genetics Reports First Quarter 2018 Financial Results
Feb 28, 2018: Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 06, 2017: Fulgent Genetics Reports Third Quarter 2017 Financial Results
Sep 14, 2017: FDNA Teams with World’s Top Genetic Labs to Advance Genetic Testing for Rare Diseases
Aug 07, 2017: Fulgent Genetics Reports Second Quarter 2017 Financial Results
May 08, 2017: Fulgent Genetics Reports First Quarter 2017 Financial Results
Feb 27, 2017: Fulgent Genetics Reports Fourth Quarter and Full Year 2016 Financial Results

Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Fulgent Genetics Inc, Key Facts
Fulgent Genetics Inc, Key Employees
Fulgent Genetics Inc, Key Employee Biographies
Fulgent Genetics Inc, Major Products and Services
Fulgent Genetics Inc, History
Fulgent Genetics Inc, Subsidiaries
Fulgent Genetics Inc, Key Competitors
Fulgent Genetics Inc, Ratios based on current share price
Fulgent Genetics Inc, Annual Ratios
Fulgent Genetics Inc, Annual Ratios (Cont...1)
Fulgent Genetics Inc, Interim Ratios
Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Fulgent Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Fulgent Genetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Fulgent Genetics Inc, Performance Chart (2014 - 2017)
Fulgent Genetics Inc, Ratio Charts
Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Fulgent Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Pathway Genomics Corp
  • Myriad Genetics Inc
  • InVitae Corp
  • GeneDX Inc
  • Foundation Medicine Inc
  • Counsyl Inc
  • Ambry Genetics Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll